BoltzGen: MIT’s Generative AI Redefines the Future of Drug Discovery Thanks to MIT’s BoltzGen, a generative AI capable of designing entirely new protein molecules, we may be entering an era of breakthrough treatments for the world’s toughest diseases. BoltzGen is setti... Biomedical research Biotechnology Drug discovery Generative AI Machine learning Open source Protein design
AI-Assisted Discovery of Small-Molecule TREM2 Agonists That Activate Microglia A new bioRxiv preprint from Weill Cornell Medicine and collaborators reports a structure-guided, AI-assisted campaign to discover and optimize small-molecule agonists of Triggering Receptor Expressed ... ADME/PK Alzheimer's disease Deep Docking Drug discovery Microglia TREM2